What we have to worry about now are specialty drug tiers. In the past there were three tiers, low cost, moderate cost, and higher cost. Insurance companies are starting to add a fourth and fifth tier that are paid with co-insurance rather than a co-payment. That means patients who need these drugs will pay a percentage of the cost instead of a fixed cost. For patients like Fiona this cost will be substantial and unaffordable. There is no generic for igg.
Healthcare reform hasn't really made healthcare affordable, but it offers Fiona some protection. I think we have a long way to go.
Healthcare reform hasn't really made healthcare affordable, but it offers Fiona some protection. I think we have a long way to go.
No comments :
Post a Comment